Global IP Protection: Data Exclusivity Is Top USTR Concern As Licensing Recedes
Executive Summary
The U.S. Trade Representative's most recent report on global intellectual property rights suggests compulsory licensing may be receding somewhat as a worry for pharmaceutical companies, but inadequate data protection remains a strong concern